Polycystic Ovarian Syndrome: Impact of Flaxseed Supplementation
Interventional
Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
To explore the effects of flaxseed supplementation on women with clinically confirmed PCOS.
baseline, 12 weeks, 24 weeks
No
Susan M Schneider, PhD
Principal Investigator
Duke University
United States: Institutional Review Board
Pro00000854
NCT00693082
August 2007
June 2009
Name | Location |
---|---|
Duke Univeristy Medical Center | Durham, North Carolina 27710 |